Benefit of Allogeneic Transplantation in Patients Age ≥ 60 Years With Acute Myeloid Leukemia Is Limited to Those in First Complete Remission at Time of Transplant
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.12.560
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2014
Authors
Publisher
Elsevier BV